| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 462 | 722 | 430 | 527 | 0 | 0 | 406 | 53 | 0 |
| Total Income - EUR | - | 462 | 722 | 430 | 527 | 0 | 0 | 406 | 53 | 0 |
| Total Expenses - EUR | - | 728 | 756 | 55 | 61 | 63 | 0 | 0 | 32 | 0 |
| Gross Profit/Loss - EUR | - | -266 | -33 | 375 | 466 | -63 | 0 | 406 | 20 | 0 |
| Net Profit/Loss - EUR | - | -280 | -55 | 362 | 450 | -63 | 0 | 394 | 17 | 0 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Zalmoxis Medicis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 145 | 387 | 744 | 867 | 456 | 446 | 854 | 856 | 851 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 430 | 0 | 0 | 0 | 406 | 5 | 5 |
| Cash | - | 145 | 387 | 314 | 867 | 456 | 446 | 447 | 851 | 846 |
| Shareholders Funds | - | -236 | -287 | 81 | 529 | 456 | 446 | 842 | 856 | 851 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 381 | 674 | 663 | 338 | 0 | 0 | 12 | 0 | 0 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Zalmoxis Medicis Srl